Reduced expression of EphB2 is significantly associated with nodal metastasis in Chinese patients with gastric cancer
- 18 March 2010
- journal article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 137 (1) , 73-80
Abstract
EphB2 is a member of the Eph receptor tyrosine kinase family that has been involved in the regulation of cytoskeleton organization and cell migration in various cell types. Its role and regulation in carcinogenesis is controversial, especially in gastric cancer. We detected EphB2 expression and determined its clinical significance and explored its underlying molecular mechanism in gastric cancers. Tissue microarray blocks containing primary gastric cancer, lymph node metastases, and adjacent normal mucosa specimens obtained from 337 Chinese patients were constructed. Expression of EphB2 in these specimens was analyzed using immunohistochemistry. Mutation analysis at the A9 tract in exon 17 and loss of heterozygosity analysis at the EphB2 gene locus were carried out in 13 sporadic EphB2-negative gastric cancers. Complete loss of EphB2 expression was observed in 177 (52.5%) of the 337 primary tumor and 41 (82%) of the 50 nodal metastases. Loss of EphB2 expression was significantly associated with advanced T stage, nodal metastasis, advanced disease stage, and poor histological differentiation. Loss of EphB2 expression correlated significantly with poor survival rates in both univariate and multivariate analysis. No frameshift mutation, but a higher frequency of allelic loss, was found in EphB2-negative primary and metastatic tumor samples. Frequent deletion and decreased expression of EphB2 protein suggested it as a negative biomarker for gastric carcinogenesis and a potential predictor of the outcome of patients with gastric cancer.Keywords
This publication has 20 references indexed in Scilit:
- Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancerClinical & Experimental Metastasis, 2008
- Fine deletion analysis of 1p36 chromosomal region in oral squamous cell carcinomasJournal of Oral Pathology & Medicine, 2008
- Genetic and epigenetic analysis of the EPHB2 gene in gastric cancersAPMIS, 2007
- High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instabilityOncogene, 2006
- The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinomaGynecologic Oncology, 2006
- Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumoursCarcinogenesis, 2005
- Prevalent mutations in prostate cancerJournal of Cellular Biochemistry, 2005
- Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancerNature Genetics, 2004
- Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancerJournal of Cancer Research and Clinical Oncology, 2002
- The Eph family: a multitude of receptors that mediate cell recognition signalsCell and tissue research, 1997